2012
DOI: 10.1002/wnan.1187
|View full text |Cite
|
Sign up to set email alerts
|

Physiological behavior of quantum dots

Abstract: Quantum dots (QDs) have shown great potentials in biomedical applications like bioimaging, sensors and diagnostics due to various advantages such as their robust fluorescence, remarkable photostability, large absorption cross section, and tunable fluorescence emission. The fate, behavior, metabolism, and toxicities of QDs are the primary aspects to be assessed before their bio-applications. Numerous studies concerning those aspects have been reported in the past years. However, only several reviews discussed t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 87 publications
0
4
0
Order By: Relevance
“…In addition to reducing the amount of nanoparticles available for accumulation at a therapeutic site, opsonization, MPS sequestration and accumulation of nanoparticles in the tissues of the MPS can lead to inflammation and release of toxic byproducts by biodegradation, as well as uncontrolled and unpredictable localization . Modified biodistribution and undesired exposure of MPS tissues to radiolabeled nanomaterials or nanoparticles carrying chemotherapeutic agents for a prolonged time can cause hematopoietic, renal or bone marrow toxicity, and results in low therapeutic efficiency as well as poor sensitivity in PET and SPECT imaging …”
Section: The Issue Of Biomolecular Corona Formationmentioning
confidence: 99%
“…In addition to reducing the amount of nanoparticles available for accumulation at a therapeutic site, opsonization, MPS sequestration and accumulation of nanoparticles in the tissues of the MPS can lead to inflammation and release of toxic byproducts by biodegradation, as well as uncontrolled and unpredictable localization . Modified biodistribution and undesired exposure of MPS tissues to radiolabeled nanomaterials or nanoparticles carrying chemotherapeutic agents for a prolonged time can cause hematopoietic, renal or bone marrow toxicity, and results in low therapeutic efficiency as well as poor sensitivity in PET and SPECT imaging …”
Section: The Issue Of Biomolecular Corona Formationmentioning
confidence: 99%
“…During the past ten years, several review articles have focused on the properties [ 2 , 13 , 14 , 15 ], applications [ 2 , 3 , 4 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 ], toxicity [ 6 , 15 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 ], synthesis [ 14 , 16 , 17 , 18 , 22 , 29 , 36 ], characterisation [ 16 , 17 , 37 , 38 , 39 , 40 ] and functionalisation [ 29 , 32 , 41 , 42 , …”
Section: Introductionmentioning
confidence: 99%
“…Reprinted from ref[94],Copyright (2007), American Chemical Society.While several types of ligands have been developed for enhancing the stability and yield of QDs in aqueous suspension the problem of aggregation and long term stability persists especially when QDs are dialyzed against buffers or water for purification following attachment of biofunctional molecules. Further advancement in the field using phosphine, peptides and cross linked dendrons have been made but these processes adds complexity to the ligand exchange process and increase the size of the QDs thereby compromising the two most unique advantages of the ligand exchange process[95].3.2 Surface silanization:The process of creating a layer of amorphous silica on the surface of nanoparticles is called silanization. The electrochemical properties of silica make it a suitable material for increasing the solubility of QDs in aqueous media while retaining most of its emission properties.…”
mentioning
confidence: 99%
“…Most developments have been made in the surface activation step of QDs for silanization. Earlier Correa-Duarte et al[95,97] exchanged the citrate coated QDs with silica coating by using(3-sulfanylprosulfanylpropyl) trimethoxysilane (MPS) as the first layer of silica followed by solvent exchange in ethanol. The silica shell was then grown in thickness using the conventional Stober process by addition of tetraethyl orthosilicate (TEOS) to the colloidal solution.…”
mentioning
confidence: 99%